CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS

Journal of Intensive Care Medicine

Volumn 26, Issue 1, 2011, Pages 34-40

  Richards, Guy ^a   Levy, Howard ^b   Laterre, Pierre Francois ^c   Feldman, Charles ^a   Woodward, Brad ^d   Bates, Becky M ^e   Qualy, Rebecca L ^d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SANGART INC   (United States)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d ELI LILLY AND COMPANY   (United States)

^e MEDTRONIC INC   (United States)

Author keywords

Acute Physiology and Chronic Health Evaluation; community acquired pneumonia; CURB 65; Pneumonia Severity Index; PROWESS; Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis; severe sepsis

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO;

ADULT; ANTIBIOTIC THERAPY; APACHE; AREA UNDER THE CURVE; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CURB 65 RATING SCALE; DISEASE SEVERITY; EARLY DIAGNOSIS; HUMAN; LUNG; MAJOR CLINICAL STUDY; MORTALITY; PNEUMONIA SEVERITY INDEX; PREDICTIVE VALUE; PRIMARY INFECTION; PRIORITY JOURNAL; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS;

AGED; ANTI-INFECTIVE AGENTS; APACHE; COMMUNITY-ACQUIRED INFECTIONS; DOUBLE-BLIND METHOD; HOSPITAL MORTALITY; HUMANS; MIDDLE AGED; PNEUMONIA; RECOMBINANT PROTEINS; RISK ASSESSMENT; ROC CURVE; SEPSIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 79251625693     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610383949     Document Type: Article

References (25)

1. Mandell LA, Wunderink R., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 ; 44 (suppl 2). S27 - S72.
2. Nathwani D., Rubinstein E., Barlow G., Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care ? Clin Infect Dis. 2001 ; 32 (5). 728-741.
3. Dean NC, Silver MP, Bateman KA, James B., Hadlock CJ, Hale D. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med. 2001 ; 110 (6). 451-457.
4. Capelastegui A., Espana PP, Quintana JM, et al. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis. 2004 ; 39 (7). 955-963.
5. Espana PP, Capelastegui A., Gorordo I., et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006 ; 174 (11). 1249-1256. (Pubitemid 44924826)
6. Valencia M., Badia JR, Cavalcanti M., et al. Pneumonia severity index class V patients with community-acquired outcomes, and value of severity scores. Chest. 2007 ; 132 (2). 515-522.
7. Capelastegui A., Espana PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006 ; 27 (1). 151-157. (Pubitemid 43092679)
8. Howell MD, Donnino MW, Talmor D., et al. Performance of severity of illness scoring systems in emergency department patients with infection. Acad Emerg Med. 2007 ; 14 (8). 709-714.
9. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 ; 336 (4). 243-250.
10. Lim WS, van der Eerden MM, Boersma WG, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 ; 58 (5). 377-382.
11. Niederman MS, Feldman C., Richards GA Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds. Eur Respir J. 2006 ; 27 (1). 9-11.
12. The British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognosis factors, and outcome. Q J Med. 1987 ; 62 (3). 195-220.
13. Conte HA, Chen YT, Mehal W., Scinto JD, Quagliarello VJ A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med. 1999 ; 106 (1). 20-28.
14. Leroy O., Devos P., Guery B., et al. Simplified prediction rule for prognosis of patients with severe community-acquired pneumonia in ICUs. Chest. 1999 ; 116 (1). 157-165.
15. Smyrnios NA, Schaefer OP, Collins RM, Madison JM Applicability of prediction rules in patients with community-acquired pneumonia requiring intensive care: a pilot study. J Intensive Care Med. 2005 ; 20 (4). 226-232.
16. Aujesky D., Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005 ; 118 (4). 384-392.
17. Kollef KE, Reichley RM, Micek ST, Kollef MH. The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillinresistant Staphylococcus aureus pneumonia. Chest. 2008 ; 133 (2). 363-369.
18. Laterre PF, Garber G., Levy H., et al. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study. Crit Care Med. 2005 ; 33 (5). 952-961.
19. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 ; 344 (10). 699-709.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE Apache II: a severity of disease classification system. Crit Care Med. 1985 ; 13 (10). 818-829.
21. Dhainaut JF, Laterre PF, LaRosa SP, et al. The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results. Crit Care Med. 2003 ; 31 (9). 2291-2301.
22. Niederman MS, Mandell LA, Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia, diagnostic assessment of severity, antimicrobial therapy, and prevention. Am Rev Respir Crit Care Med. 2001 ; 163 (7). 1730-1754.
23. DeLong ER, DeLong DM, Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1998 ; 44 (3). 837-845.
24. Booth FV, Short MA, Arkins N., et al. Application of a population-based severity scoring system to individual patients results in frequent misclassification. Crit Care. 2005 ; 9 (5). R522 - R529.
25. Krüger S., Ewig S., Marre R., et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J. 2008 ; 31 (2). 349-355.